Ultibro Breezhaler {Indacaterol + Glycopyrronium (110 mcg+ 50 mcg)} is indicated for bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
The combination of indacaterol and glycopyrronium is prescribed for the long-term treatment of airflow obstruction in individuals with chronic obstructive pulmonary disease (COPD).
Drinking alcohol while using Ultibro Breezhaler is unsafe.
Consult your doctor before using Ultibro Breezhaler during pregnancy. Limited human studies suggest potential risks to the developing baby, so your doctor will evaluate the benefits versus risks before prescribing it.
Ultibro Breezhaler is likely safe to use while breastfeeding if prescribed. Limited data suggest it poses minimal risk to the baby, although long-term use might reduce milk production.
No interactions have been found with driving.
No interactions have been found with kidney or liver function.
No interactions have been found with kidney or liver function.
Ultibro Breezhaler contains Indacaterol and Glycopyrrolate, which relax airway muscles (Indacaterol) and decrease airway secretions (Glycopyrrolate), making breathing easier for COPD patients.
Side effects may include indigestion, high blood pressure, inflammation of the throat and nasal passages, chest pain, fever, urinary retention, sore throat, cough, headache, dizziness, allergic reactions, increased blood glucose level, inflammation of the nose, sinus inflammation, and urinary tract infection.
Ultibro Breezhaler is prescribed for chronic obstructive pulmonary disease (COPD), relaxing airway muscles to ease breathing. It should be used regularly, even if symptoms improve, to maintain effectiveness. This medication should not be used for sudden shortness of breath.
Indacaterol Maleate is a specific β2-adrenergic agonist with the chemical name (R)-5-[2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl]-8 hydroxy-1H-quinolin-2-one maleate. Glycopyrronium is a long-acting, selective antimuscarinic agent that inhibits M3 receptors, leading to smooth muscle relaxation in the airways.
Dosage: Adults with COPD should inhale one capsule with the inhaler once daily. Adjustments may be needed for hepatic or renal impairment.
For inhalation use only; the capsules should not be swallowed.
Indacaterol may interact with adrenergic drugs, xanthine derivatives, steroids, diuretics, monoamine oxidase inhibitors, tricyclic antidepressants, QTc prolonging drugs, beta-blockers, inhibitors of cytochrome P450 3A4, and P-gp efflux transporter.
Ultibro Breezhaler is contraindicated in patients with hypersensitivity to its components, those with asthma not treated with a long-term control medication, and children under 18 years old.
Limited data are available on the use of indacaterol and glycopyrronium combination in pregnant women. Animal studies do not indicate direct or indirect harmful effects, but caution is advised. It should not be used during pregnancy or breastfeeding unless the benefits outweigh the risks.
Ultibro Breezhaler should be used cautiously in patients with certain medical conditions, including narrow-angle glaucoma, urinary retention, cardiovascular disorders, convulsive disorders, severe renal impairment, hypokalemia, hyperglycemia, and during pregnancy and lactation.
Store below 30°C, away from light and moisture, and out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.